The 2012 Hematopoietic Database is for use with cases diagnosed 01/01/2012 and forward. For cases diagnosed 01/01/2010-12/31/2011, use the 2010 database.
| # | ICD-O-3 Code | ICD-O-3 Name | Reportable |
|---|---|---|---|
| 1 | 9590/3 | Malignant lymphoma, NOS | Yes |
| 2 | 9591/3 | Non-Hodgkin lymphoma, NOS | Yes |
| 3 | 9596/3 | B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma | Yes |
| 4 | 9597/3 | Primary cutaneous follicle centre lymphoma | Yes |
| 5 | 9650/3 | Classical Hodgkin lymphoma | Yes |
| 6 | 9651/3 | Lymphocyte-rich classical Hodgkin lymphoma | Yes |
| 7 | 9652/3 | Mixed cellularity classical Hodgkin lymphoma | Yes |
| 8 | 9653/3 | Lymphocyte-depleted classical Hodgkin lymphoma | Yes |
| 9 | 9654/3 | Hodgkin lymphoma, lymphocytic depletion, diffuse fibrosis [OBS] see Abstractor Note | Yes |
| 10 | 9655/3 | Hodgkin lymphoma, lymphocyte depletion, reticular | Yes |
| 11 | 9657/3 | Hodgkin disease, lymphocytic predominance, NOS [OBS] see 9651/3 | Yes |
| 12 | 9658/3 | Hodgkin disease, lymphocytic predominance, diffuse [OBS] see 9651/3 | Yes |
| 13 | 9659/3 | Nodular lymphocyte predominant Hodgkin lymphoma | Yes |
| 14 | 9661/3 | Hodgkin granuloma {obs} | Yes |
| 15 | 9662/3 | Hodgkin sarcoma [OBS] | Yes |
| 16 | 9663/3 | Nodular sclerosis classical Hodgkin lymphoma | Yes |
| 17 | 9664/3 | Hodgkin lymphoma, nodular sclerosis, cellular phase [OBS] see 9663/3 | Yes |
| 18 | 9665/3 | Hodgkin lymphoma, nodular sclerosis, grade 1 [OBS] see 9663/3 | Yes |
| 19 | 9667/3 | Hodgkin lymphoma, nodular sclerosis, grade 2 [OBS] see 9663/3 | Yes |
| 20 | 9670/3 | Malignant lymphoma, small B lymphocytes, NOS [OBS] see 9823/3 | Yes |
| 21 | 9671/3 | Lymphoplasmacytic lymphoma | Yes |
| 22 | 9673/3 | Mantle cell lymphoma | Yes |
| 23 | 9675/3 | Malignant lymphoma, mixed small and large cell, diffuse [OBS] see 9690/3 | Yes |
| 24 | 9678/3 | Primary effusion lymphoma | Yes |
| 25 | 9679/3 | Primary mediastinal (thymic) large B-cell lymphoma | Yes |
| 26 | 9680/3 | Diffuse large B-cell lymphoma (DLBCL) | Yes |
| 27 | 9684/3 | Malignant lymphoma, large B-cell, diffuse, immunoblasticc, NOS [OBS] See 9680/3 | Yes |
| 28 | 9687/3 | Burkitt lymphoma | Yes |
| 29 | 9688/3 | T-cell histiocyte-rich large B-cell lymphoma | Yes |
| 30 | 9689/3 | Splenic marginal zone lymphoma | Yes |
| 31 | 9690/3 | Follicular lymphoma | Yes |
| 32 | 9691/3 | Follicular lymphoma, grade 2 | Yes |
| 33 | 9695/3 | Follicular lymphoma, grade 1 | Yes |
| 34 | 9698/3 | Follicular lymphoma, grade 3 | Yes |
| 35 | 9699/3 | Extranodal marginal zone lymphoma of mucosal-associated lymphoid tissue (MALT lymphoma) | Yes |
| 36 | 9700/3 | Mycosis fungoides | Yes |
| 37 | 9701/3 | Sezary syndrome | Yes |
| 38 | 9702/3 | Peripheral T-cell lymphoma, NOS | Yes |
| 39 | 9705/3 | Angioimmunoblastic T-cell lymphoma | Yes |
| 40 | 9708/3 | Subcutaneous panniculitis-like T-cell lymphoma | Yes |
| 41 | 9709/3 | Primary cutaneous T-cell lymphoma | Yes |
| 42 | 9712/3 | Intravascular large B-cell lymphoma | Yes |
| 43 | 9714/3 | Anaplastic large cell lymphoma, ALK-positive | Yes |
| 44 | 9716/3 | Hepatosplenic T-cell lymphoma | Yes |
| 45 | 9717/3 | Enteropathy-associated T-cell lymphoma | Yes |
| 46 | 9718/1 | Lymphomatoid papulosis | No |
| 47 | 9718/3 | Primary cutaneous CD30-positive T-cell lymphoproliferative disorders | Yes |
| 48 | 9719/3 | Extranodal NK--/T-cell lymphoma, nasal type | Yes |
| 49 | 9724/3 | Systemic EBV-positive T-cell lymphoproliferative disease of childhood | Yes |
| 50 | 9725/3 | Hydroa vacciniforme-like lymphoma | Yes |
| 51 | 9726/3 | Primary cutaneous gamma delta T-cell lymphoma | Yes |
| 52 | 9727/3 | Blastic plasmacytoid dendritic cell neoplasm | Yes |
| 53 | 9728/3 | Precursor B-lymphoblastic lymphoma [OBS] See 9811/3 | Yes |
| 54 | 9729/3 | Precursor T--cell lymphoblastic lymphoma, NOS [OBS] See 9837/3 | Yes |
| 55 | 9731/3 | Solitary plasmacytoma of bone | Yes |
| 56 | 9732/3 | Plasma cell myeloma | Yes |
| 57 | 9733/3 | Plasma cell leukemia [OBS] See 9732/3 | Yes |
| 58 | 9734/3 | Extraosseous plasmacytoma | Yes |
| 59 | 9735/3 | Plasmablastic lymphoma | Yes |
| 60 | 9737/3 | ALK-positive large B-cell lymphoma | Yes |
| 61 | 9738/3 | Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease | Yes |
| 62 | 9740/1 | Solitary mastocytoma of skin | No |
| 63 | 9740/3 | Mast cell sarcoma | Yes |
| 64 | 9741/3 | Systemic mastocytosis | Yes |
| 65 | 9742/3 | Mast cell leukemia | Yes |
| 66 | 9750/3 | Malignant histiocytosis [OBS] see 9751/3 | Yes |
| 67 | 9751/3 | Langerhans cell histiocytosis | Yes |
| 68 | 9752/1 | Langerhans cell histiocytosis, unifocal [OBS] see 9751/3 | Yes |
| 69 | 9753/1 | Langerhans cell histiocytosis, multifocal [OBS] see 9751/3 | Yes |
| 70 | 9754/3 | Langerhans cell histiocytosis, disseminated [OBS] see 9751/3 | Yes |
| 71 | 9755/3 | Histiocytic sarcoma | Yes |
| 72 | 9756/3 | Langerhans cell sarcoma | Yes |
| 73 | 9757/3 | Interdigitating dendritic cell sarcoma | Yes |
| 74 | 9758/3 | Follicular dendritic cell sarcoma | Yes |
| 75 | 9759/3 | Fibroblastic reticular cell tumor | Yes |
| 76 | 9760/3 | Immunoproliferative disease, NOS [OBS] | Yes |
| 77 | 9761/3 | Waldenstrom macroglobulinemia | Yes |
| 78 | 9762/3 | Heavy chain disease | Yes |
| 79 | 9764/3 | Immunoproliferative small intestinal disease [OBS] see code 9762 | Yes |
| 80 | 9765/1 | MGUS | No |
| 81 | 9766/1 | Angiocentric immunoproliferative lesion | No |
| 82 | 9767/1 | Angioimmunoblastic lymphadenopathy | No |
| 83 | 9768/1 | T gamma - lymphoproliferative disorder | No |
| 84 | 9769/1 | Immunoglobulin deposition disease | No |
| 85 | 9800/3 | Leukemia, NOS | Yes |
| 86 | 9801/3 | Acute undifferentiated leukemia | Yes |
| 87 | 9805/3 | Acute biphenotypic leukemia [OBS] | Yes |
| 88 | 9806/3 | Mixed phenotype acute leukemia with t(9;22)(q34;q11.2);BCR-ABL1 | Yes |
| 89 | 9807/3 | Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged | Yes |
| 90 | 9808/3 | Mixed phenotype acute leukemia, B/myeloid, NOS | Yes |
| 91 | 9809/3 | Mixed phenotype acute leukemia, T/myeloid, NOS | Yes |
| 92 | 9811/3 | B lymphoblastic leukemia/lymphoma, NOS | Yes |
| 93 | 9812/3 | B Lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1 | Yes |
| 94 | 9813/3 | B Lymphoblastic leukemia/lymphoma with t(v;11q23); MLL rearranged | Yes |
| 95 | 9814/3 | B Lymphoblastic leukemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) | Yes |
| 96 | 9815/3 | B Lymphoblastic leukemia/lymphoma with hyperdiploidy | Yes |
| 97 | 9816/3 | B Lymphoblastic leukemia/lymphoma with hypodiploidy (Hypodiploid ALL) | Yes |
| 98 | 9817/3 | B Lymphoblastic leukemia/lymphoma with t(5;14)(q31;q32); IL3-IGH | Yes |
| 99 | 9818/3 | B Lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3);E2A-PBX1 (TCF3-PBX1) | Yes |
| 100 | 9820/3 | Lymphoid leukemia, NOS | Yes |
| 101 | 9823/3 | Chronic lymphocytic leukemia/small lymphocytic lymphoma | Yes |
| 102 | 9826/3 | Burkitt cell leukemia | Yes |
| 103 | 9827/3 | Adult T-cell leukemia/lymphoma (HTLV-1 positive) | Yes |
| 104 | 9831/3 | T-cell large granular lymphocytic leukemia | Yes |
| 105 | 9832/3 | Prolymphocytic leukemia, NOS | Yes |
| 106 | 9833/3 | B-cell prolymphocytic leukemia | Yes |
| 107 | 9834/3 | T-cell prolymphocytic leukemia | Yes |
| 108 | 9835/3 | Precursor cell lymphoblastic leukemia, NOS [OBS} see 9811/3 | Yes |
| 109 | 9836/3 | Precursor B-cell lymphoblastic leukemia [OBS} see code 9811/3 | Yes |
| 110 | 9837/3 | Adult T-cell leukemia/lymphoma | Yes |
| 111 | 9840/3 | Acute erythroid leukemia | Yes |
| 112 | 9860/3 | Myeloid leukemia, NOS | Yes |
| 113 | 9861/3 | Acute myeloid leukemia, NOS | Yes |
| 114 | 9863/3 | Chronic myeloid leukemia, NOS | Yes |
| 115 | 9865/3 | Acute myeloid leukemia with t(6;9)(p23;q34);DEK-NUP214 | Yes |
| 116 | 9866/3 | Acute promyelocytic leukemia (AML with t(15;17)(q22;q12)) PML/RARA | Yes |
| 117 | 9867/3 | Acute myelomonocytic leukemia | Yes |
| 118 | 9869/3 | Acute myeloid leukemia with inv(3)(q21;q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1 | Yes |
| 119 | 9870/3 | Acute basophilic leukemia | Yes |
| 120 | 9871/3 | Acute myeloid leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22), CBFB-MYH11 | Yes |
| 121 | 9872/3 | Acute myeloid leukemia with minimal differentiation | Yes |
| 122 | 9873/3 | Acute myeloid leukemia without maturation | Yes |
| 123 | 9874/3 | Acute myeloblastic leukemia with maturation | Yes |
| 124 | 9875/3 | Chronic myelogenous leukemia, BCR/ABL1 positive | Yes |
| 125 | 9876/3 | Atypical chronic myeloid leukemia, BCR-ABL1 negative | Yes |
| 126 | 9891/3 | Acute monoblastic and monocytic leukemia | Yes |
| 127 | 9895/3 | Acute myeloid leukemia with myelodysplasia-related changes | Yes |
| 128 | 9896/3 | Acute myeloid leukemia, t(8;21)(q22;q22) RUNX1-RUNX1T1 | Yes |
| 129 | 9897/3 | Acute myeloid leukemia with t(9;11)(p22;q23);MLLT3-MLL | Yes |
| 130 | 9898/1 | Myeloid proliferations related to Down syndrome | No |
| 131 | 9898/3 | Myeloid leukemia associated with Down Syndrome | Yes |
| 132 | 9910/3 | Acute megakaryoblastic leukemia | Yes |
| 133 | 9911/3 | Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1 | Yes |
| 134 | 9920/3 | Therapy-related myeloid neoplasm | Yes |
| 135 | 9930/3 | Myeloid sarcoma | Yes |
| 136 | 9931/3 | Acute panmyelosis with myelofibrosis | Yes |
| 137 | 9940/3 | Hairy Cell Leukemia | Yes |
| 138 | 9945/3 | Chronic myelomonocytic leukemia | Yes |
| 139 | 9946/3 | Juvenile myelomonocytic leukemia | Yes |
| 140 | 9948/3 | Aggressive NK-cell leukemia | Yes |
| 141 | 9950/3 | Polycythemia vera | Yes |
| 142 | 9960/3 | Chronic myeloproliferative disease, NOS [OBS] see 9975/3 | Yes |
| 143 | 9961/3 | Primary myelofibrosis | Yes |
| 144 | 9962/3 | Essential thrombocythemia | Yes |
| 145 | 9963/3 | Chronic neutrophilic leukemia | Yes |
| 146 | 9964/3 | Chronic eosinophilic leukemia, NOS | Yes |
| 147 | 9965/3 | Myeloid and lymphoid neoplasms with PDGFRA rearrangement | Yes |
| 148 | 9966/3 | Myeloid neoplasms with PDGFRB rearrangement | Yes |
| 149 | 9967/3 | Myeloid and lymphoid neoplasms with FGFR1 abnormalities | Yes |
| 150 | 9970/1 | Lymphoproliferative disorder, NOS | No |
| 151 | 9971/1 | Plasmacytic hyperplasia | No |
| 152 | 9971/3 | Post transplant lymphoproliferative disorder | Yes |
| 153 | 9975/3 | Myelodysplastic/myeloproliferative neoplasm unclassifiable | Yes |
| 154 | 9980/3 | Refractory anemia | Yes |
| 155 | 9982/3 | Refractory anemia with ring sideroblasts | Yes |
| 156 | 9983/3 | Refractory anemia with excess blasts | Yes |
| 157 | 9984/3 | Refractory anemia with excess blasts in transformation [OBS] see 9983 | Yes |
| 158 | 9985/3 | Refractory cytopenia with multilineage dysplasia | Yes |
| 159 | 9986/3 | Myelodysplastic syndrome associated with isolated del(5q) | Yes |
| 160 | 9987/3 | Therapy related myelodysplastic syndrome, NOS [OBS] See 9920/3 | Yes |
| 161 | 9989/3 | Myelodysplastic syndrome, unclassifiable | Yes |
| 162 | 9991/3 | Refractory neutropenia | Yes |
| 163 | 9992/3 | Refractory thrombocytopenia | Yes |
